Viatris VTRS
NASDAQ VTRS
$16.44 -0.17 (-0.99%)
As of: Sep 9, 2026 · 3:06 PM EDT

Viatris (VTRS) Other Working Capital Changes (2019 - 2026)

Viatris (VTRS) posted Other Working Capital Changes of $141.0 million for Q2 2026, up 515.72% on a QoQ basis from $22.9 million in Q1 2026, and down 64.43% year-over-year from $396.4 million in Q2 2025.

Analysis

Viatris (VTRS) Other Working Capital Changes (2019 - 2026) Analysis & Trends

Viatris has reported Other Working Capital Changes for 8 years, with the latest figure at $141.0 million in Q2 2026.

  • On a quarterly basis, Other Working Capital Changes fell 64.43% year-over-year to $141.0 million in Q2 2026; TTM through Jun 2026 was $224.0 million, a 60.24% decrease from a year earlier, with the FY2025 full-year figure at $633.7 million, up 320.78% from the prior year.
  • Other Working Capital Changes was $141.0 million for Q2 2026 at Viatris, up from $22.9 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $483.5 million in Q4 2022, with the low at -$263.4 million in Q3 2023.
  • Average Other Working Capital Changes over 5 years is $110.1 million, with a median of $121.2 million recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes sank 301.68% in 2023, then surged 708.98% in 2025.
  • Over 5 years, Other Working Capital Changes stood at $483.5 million in 2022, then plunged by 45.83% to $261.9 million in 2023, then tumbled by 66.28% to $88.3 million in 2024, then slumped by 54.81% to $39.9 million in 2025, then soared by 253.38% to $141.0 million in 2026.
  • The last three Other Working Capital Changes figures came in at $141.0 million (Q2 2026), $22.9 million (Q1 2026), and $39.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.53 Bn 38.88 Bn 2.15 Bn
2 Viatris 19.14 Bn 18.25 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.45 Bn 5.33 Bn 334.51 Mn
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn
9 Fennec Pharmaceuticals 400.20 Mn 358.95 Mn 17.15 Mn
10 RedHill Biopharma 178.79 Mn 178.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 141.00 Mn
Jun 30, 2026 141.00 Mn
Mar 31, 2026 22.90 Mn
Mar 31, 2026 22.90 Mn
Dec 31, 2025 39.90 Mn
Dec 31, 2025 39.90 Mn
Sep 30, 2025 20.20 Mn
Sep 30, 2025 20.20 Mn
Jun 30, 2025 396.40 Mn
Jun 30, 2025 396.40 Mn
Mar 31, 2025 177.20 Mn
Mar 31, 2025 177.20 Mn
Dec 31, 2024 88.30 Mn
Dec 31, 2024 88.30 Mn
Sep 30, 2024 -98.50 Mn
Sep 30, 2024 -98.50 Mn
Jun 30, 2024 49.00 Mn
Jun 30, 2024 49.00 Mn
Mar 31, 2024 111.80 Mn
Mar 31, 2024 111.80 Mn